“Female Viagra” – Wonder Drug, Or Just Another Way To Scam Women?

See if you can spot the three signs of a possible drug marketing scam. 

| HealthLine – The FDA has recently approved a Viagra-like drug, flibanserin (Addyi), for treatment of female sexual interest/arousal disorder (FSIAD) in premenopausal women.

[First clue of a possible marketing scam: invention and naming of a new disease. – Editor]

Currently, Addyi is only available through certain prescribers and pharmacies.

It’s prescribed by approved providers in an agreement between the manufacturer and the FDA. A prescriber must be certified by the manufacturer to meet certain FDA requirements.

The FDA hasn’t approved Viagra itself for women to use. But it has been prescribed off-label for women with a low sex drive. Evidence of its effectiveness is mixed at best.

A review of trials of Viagra in women speculates that positive results are observed in regard to physical arousal. However, this is not the case for the more complex nature of FSIAD.

For example, the review detailed a study that gave Viagra to 202 postmenopausal women with primary FSIAD.

Researchers observed an increased amount of arousal sensations, vaginal lubrication, and orgasm in study participants.

However, women with secondary FSIAD-associated disorders reported no increase in desire or enjoyment.

A second study discussed in the review found that both pre- and postmenopausal women reported no significant positive responses when using Viagra.

Purpose and benefits

There are several reasons that women would seek out a Viagra-like pill.

[Second clue of a possible marketing scam: say that the new drug is “like” a bestselling drug. – Editor]

As they approach middle age and beyond, it’s not uncommon for women to observe a decrease in their overall sex drive.

A decrease in sex drive can also originate from daily stressors, significant life events, or chronic conditions such as multiple sclerosis or diabetes.

However, some women observe a decrease or absence in sex drive due to a condition called female sexual interest/arousal disorder. [There it is again. – Ed.]

FSIAD has also been referred to as hypoactive sexual desire disorder (HSDD). [This disease has two names – it must be really bad.] According to one expert panel and review, FSIAD is estimated to affect about 10 percent of adult women. It’s characterized by the following symptoms:

  • limited or absent sexual thoughts or fantasies
  • reduced or absent response of desire to sexual cues or stimulation
  • loss of interest or inability to maintain interest in sexual activities
  • significant feelings of frustration, incompetence, or worry at the lack of sexual interest or arousal

How does flibanserin work?

Flibanserin was originally developed as an antidepressant, but was approved by the FDA for treatment of FSIAD in 2015 …

[Third clue of a possible marketing scam: it’s a drug in search of a disease and a market. – Editor]

(Read more.) 

RELATED: 

80 Women Sue CA Hospital Over ‘Crotch Cams

Millions of Women Given Incorrect UTI Test Results

Man sues CVS after wife discovers Viagra prescription

MORE OF TODAY’S TOP HEALTH NEWS: 

McDonald’s Rolls Out ‘United Nations’ Menu (SSDD)

“Vaccines Are Sorcery,” Insists Controversial Texas Rep.

Killer Third-World Diseases Spread As Antibiotics Quickly Grow Useless

Giant Sucking Sound? It’s Big Rx Siphoning Off $575 From Your Wallet